期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Follicular Dendritic Cell Sarcoma: A Rare Case Study of Meta-Synchronous Double Primary Cancers Follicular Dendritic Sarcoma and Invasive Breast Cancer
1
作者 emad mohsen barsoum Sara El Sherif +1 位作者 May Gamal Ashour mohsen Samy barsoum 《Journal of Cancer Therapy》 2022年第6期331-336,共6页
Follicular dendritic cell sarcomas (FDC-Sarcoma) are a rare type of tumor. Although most cases (60%) originate in the cervical, abdominal, or axillary lymph nodes, extranodal origin from secondary lymphatic tissue suc... Follicular dendritic cell sarcomas (FDC-Sarcoma) are a rare type of tumor. Although most cases (60%) originate in the cervical, abdominal, or axillary lymph nodes, extranodal origin from secondary lymphatic tissue such as the tonsils, Waldeyer’s ring, or MALT is also prevalent (40%). We report a case of cervical FDCS in a 51-year-old female who developed invasive breast cancer during follow-up. We review the presentation and management of this disorder, emphasizing the differential diagnosis. The patient was continuously monitored and has been free of recurrences for ten years. For FDC Sarcoma of the head and neck, this case suggests surgical resection combined with chemotherapy and radiotherapy as a therapeutic option. 展开更多
关键词 Follicular Dendritic Sarcoma FDCS STS Breast Cancer
下载PDF
Thirty-Four Months Control of Frail Patient with Multisystemic Affection Proved Erdheim Chester Disease: A Case Report
2
作者 emad mohsen barsoum Fiby Samir Boules +1 位作者 May Gamal Ashour mohsen Samy barsoum 《Journal of Cancer Therapy》 2021年第12期689-694,共6页
Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51</span></span><span style="font-family:Verdana;"... Erdheim-Chester disease (ECD) is a rare non-Langerhans form of histiocytosis characterized by multisystemic involvement. We report a case of a 51</span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">year</span></span></span><span style="font-family:Verdana;"><span style="font-family:Verdana;"><span style="font-family:Verdana;">-</span></span></span><span><span><span style="font-family:""><span style="font-family:Verdana;">old male patient treated with pegylated IFN-</span><i><span style="font-family:Verdana;">α</span></i><span style="font-family:Verdana;"> in a monthly schedule with low-dose prednisolone and achieved 34 months of control with minimal side effects. 展开更多
关键词 Erdheim-Chester Disease Histiocytoses Non-Langerhans Cell Histiocytoses
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部